Molecular Partners Ag (MOLN) Current Leases (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Current Leases of $2727.7 for Q1 2026, up 101.02% year-on-year from $1356.9 in Q1 2025, and down 10.58% on a QoQ basis from $3050.4 in Q4 2025.
Molecular Partners Ag (MOLN) Current Leases (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Current Leases for 7 consecutive years, with $2727.7 the latest figure, recorded in Q1 2026.
- Quarterly Current Leases rose 101.02% year-over-year to $2727.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2727.7 (up 101.02% YoY) and the FY2025 annual result came in at $3050.4, down 99.78% from the prior year.
- Current Leases fell to $2727.7 in Q1 2026 per MOLN's latest filing, from $3050.4 in the prior quarter.
- Over the last five years, Current Leases for MOLN reached as high as $4.4 million in Q2 2022 and fell as low as $1356.9 in Q1 2025.
- A 5-year average of $815407.6 and a median of $3621.9 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2025 — Current Leases tumbled 99.93% — and 2026, when it surged 101.02%.
- Year by year, Current Leases stood at $1.2 million in 2022, then climbed by 9.51% to $1.4 million in 2023, then advanced by 2.01% to $1.4 million in 2024, then sank by 99.78% to $3050.4 in 2025, then decreased by 10.58% to $2727.7 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $2727.7, $3050.4, and $1530.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - | 2,727.68 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,727.68 |
| Dec 31, 2025 | 3,050.35 |
| Sep 30, 2025 | 1,530.13 |
| Jun 30, 2025 | 1,476.04 |
| Mar 31, 2025 | 1,356.95 |
| Dec 31, 2024 | 1.39 Mn |
| Sep 30, 2024 | 1,768.25 |
| Jun 30, 2024 | 2.03 Mn |
| Mar 31, 2024 | 2,452.91 |
| Dec 31, 2023 | 1.36 Mn |
| Sep 30, 2023 | 3,110.02 |
| Jun 30, 2023 | 3.39 Mn |
| Mar 31, 2023 | 3,621.89 |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 4,092.12 |
| Jun 30, 2022 | 4.41 Mn |
| Mar 31, 2022 | 4,927.86 |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | 5,606.84 |
| Dec 31, 2020 | 1.30 Mn |